NICOLE HOLLEK: Open Payments
NPI 1881355907 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 31 payments from 10 companies in 2025. Trend: 2023 $522 · 2024 $930 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $378 |
| Lilly USA, LLC | 10 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $38 |
| Amgen Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: FARXIGA, JARDIANCE, AIRSUPRA, MOUNJARO, OTEZLA, REXULTI, Ozempic, BREZTRI.
Industry payments across CA — which companies pay providers there.
